These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32638371)

  • 1. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
    Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
    Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
    Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
    J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.
    Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP
    J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
    Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
    Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    Chouhan H; Sammour T; Thomas ML; Moore JW
    J Surg Oncol; 2018 Dec; 118(8):1311-1317. PubMed ID: 30399198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omission of Adjuvant Chemotherapy Is Associated With Increased Mortality in Patients With T3N0 Colon Cancer With Inadequate Lymph Node Harvest.
    Wells KO; Hawkins AT; Krishnamurthy DM; Dharmarajan S; Glasgow SC; Hunt SR; Mutch MG; Wise P; Silviera ML
    Dis Colon Rectum; 2017 Jan; 60(1):15-21. PubMed ID: 27926553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
    Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
    ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients.
    Birkett RT; Chamely E; Concors SJ; Bleier JI; Aarons CB; Shanmugan S; Saur NM; Paulson EC
    Clin Colorectal Cancer; 2019 Dec; 18(4):292-300. PubMed ID: 31447135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
    Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
    Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
    Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.
    O'Connor ES; Greenblatt DY; LoConte NK; Gangnon RE; Liou JI; Heise CP; Smith MA
    J Clin Oncol; 2011 Sep; 29(25):3381-8. PubMed ID: 21788561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
    Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M
    Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative Radiation for Pathologic Stage T4 Colon Cancers Receiving Adjuvant Chemotherapy.
    Margalit O; Mamtani R; Lawrence YR; Yang YX; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
    Clin Colorectal Cancer; 2019 Sep; 18(3):226-230.e2. PubMed ID: 31097386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status on microsatellite instability, prognosis and adjuvant therapy in colon cancer: A nationwide survey of medical oncologists, colorectal surgeons and gastrointestinal pathologists.
    Toh JWT; Mahajan H; Chapuis P; Spring K
    Cancer Rep (Hoboken); 2021 Feb; 4(1):e1297. PubMed ID: 33030308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.
    Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M
    Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of Adjuvant Radiotherapy for Resected Colon Cancer and Its Effect on Outcome.
    Wegner RE; Abel S; Monga D; Raj M; Finley G; Nosik S; McCormick J; Kirichenko AV
    Ann Surg Oncol; 2020 Mar; 27(3):825-832. PubMed ID: 31720934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of high-risk features for stage II adenocarcinoma of the appendix.
    Akce M; Zakka K; Penley M; Jiang R; Khalil L; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
    Cancer Treat Res Commun; 2021; 27():100329. PubMed ID: 33609973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer.
    Koenig JL; Toesca DAS; Harris JP; Tsai CJ; Haraldsdottir S; Lin AY; Pollom EL; Chang DT
    Am J Clin Oncol; 2019 Jul; 42(7):573-580. PubMed ID: 31166206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.